ProPhase Labs Inc (NASDAQ:PRPH) shares, rose in value on Wednesday, June 18, with the stock price up by 4.69% to the previous day’s close as strong demand from buyers drove the stock to $0.37.
Actively observing the price movement in the last trading, the stock closed the session at $0.35, falling within a range of $0.33 and $0.3852. The value of beta (5-year monthly) was -0.415. Referring to stock’s 52-week performance, its high was $4.68, and the low was $0.22. On the whole, PRPH has fluctuated by 14.29% over the past month.
With the market capitalization of ProPhase Labs Inc currently standing at about $15.22 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-20.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PRPH’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of PRPH currently trading nearly 4.65% and 10.28% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 54.66, while the 7-day volatility ratio is showing 3.65% which for the 30-day chart, stands at 5.47%. Furthermore, ProPhase Labs Inc (PRPH)’s beta value is -0.44, and its average true range (ATR) is 0.04.
A comparison of ProPhase Labs Inc (PRPH) with its peers suggests the former has fared considerably weaker in the market. PRPH showed an intraday change of 4.69% in last session, and over the past year, it shrunk by -92.02%%.
Data on historical trading for ProPhase Labs Inc (NASDAQ:PRPH) indicates that the trading volumes over the past 10 days have averaged 7.23 and over the past 3 months, they’ve averaged 2.84 million. According to company’s latest data on outstanding shares, there are 41.54 million shares outstanding.
Nearly 11.73% of ProPhase Labs Inc’s shares belong to company insiders and institutional investors own 12.02% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.32 million shares as on 2025-05-30, resulting in a short ratio of 0.17. According to the data, the short interest in ProPhase Labs Inc (PRPH) stood at 84.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 0.46 million. The stock has fallen by -51.60% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PRPH stock heading into the next quarter.
